Publications by authors named "Anand A Patel"

Claim this Profile
C
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study.
Irfan Yasin, Anna Stengel, Haipeng Shao, Amandeep Kaur, Emily F Mason, Anand A Patel

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.
Andrew Palmer, Garth Rauscher, Alexa Schoen, Madelyn Burkart, Ashley Dunton, Anand Ashwin Patel

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials.
Andrew Hantel, Yating Wang, Angel Cronin, Irum Khan, Ivy Elizabeth Abraham, Anand A Patel

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.
Miles Thomas, Hannah Johnston, Emily Dworkin, Austin Wesevich, Gregory W Roloff, Anand A Patel

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.
Talha Badar, James M Foran, Jan Philipp Bewersdorf, Yu-Hung Wang, Alexander Coltoff, Anand A Patel

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Anand A Patel

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms.
Joseph Cannova, Shiv Shah, Anand A Patel

Clin Lymphoma Myeloma Leuk· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Samuel J Yates, Julian J Weiss, Abigail Sneider, Emily Geramita, Guru Subramanian Guru Murthy, Anand Ashwin Patel

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study.
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Anand A Patel

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy.
Rafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, Austin Wesevich, Gregory W Roloff, Anand A Patel

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.
Reid Shaw, James J Yoon, Hannah Johnston, Marta B Davidson, Alexa J Siddon, Anand A Patel

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and outcomes of patients with mutated accelerated/blast-phase myeloproliferative neoplasms.
Leah A Goldberg, James J Yoon, Hannah Johnston, Marta B Davidson, Alexa Siddon, Anand A Patel

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia.
Anand A Patel, Raajit K Rampal

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms.
Emily O Symes, Peng Wang, Payal Sojitra, Madhu P Menon, Anand A Patel

Br J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna, Anand A Patel

Am J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD58 expression does not impact response to inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemia.
Rafael Madero-Marroquin, Ryan W Hunter, Caner Saygin, Hannah Johnston, Adam S DuVall, Anand A Patel

EJHaem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.
Chenyu Lin, Anand A Patel, Dezheng Huo, Theodore Karrison, Koen van Besien

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy.
Rohan K Achar, Benjamin J McCormick, Emily Dworkin, Emily M Geramita, Annie Im, Anand A Patel

Leuk Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome.
Muriel R Battaglia, Joseph Cannova, Rafael Madero-Marroquin, Anand A Patel

Curr Treat Options Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.
Andrew Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Anand A Patel

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia.
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Anand A Patel

EJHaem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
Anand A Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory M Shallis

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome.
Muriel R Battaglia, Joseph Cannova, Rafael Madero-Marroquin, Anand A Patel

Curr Treat Options Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, Haris Ali, Mariana Castells, Ami Patel, Anand A Patel

J Natl Compr Canc Netw· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.
Amandeep Kaur, Alexandra E Rojek, Emily Symes, Mariam T Nawas, Anand A Patel, Jay L Patel, Ami B Patel

Blood Cancer J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis